Does how ill a person gets depend on whether they are infected by a cow or a bird? There are two main variants of H5N1 that researchers are monitoring: one, called B3.13, is spreading mainly in cows; the other, called D1.1, is found mostly in wild and domesticated birds, including chickens raised for poultry. Huge amounts of bird-flu virus found in raw milk of infected cows B3.13 has spread rapidly in cattle across the United States, infecting more than 900 herds across 16 states, and has also infected other animals, such as cats, skunks and poultry. Infected cows and their milk contain high levels of the virus, making it easy for the pathogen to be transmitted between animals and workers on dairy farms, where milking equipment can spray liquid into the air and milk can coat surfaces. At least 40 people have been infected by sick cows in North America, but in these cases, the virus has caused only mild respiratory illness and an inflammatory eye condition known as conjunctivitis. At least 24 people have become ill after exposure to sick birds, and 2 of these infections, caused by D1.1, were severe — one person was in hospital for months and the other died. The H5N1 avian influenza virus (blue) revealed in a coloured image from a transmission electron microscope.Credit: CDC/Science Photo Library
GenBio Inc.
Biotechnology Research
Aliso Viejo, CALIFORNIA 348 followers
Expanding Possibilities
About us
GenBio Inc. is a US-based biotechnology company that undertakes specialized phytochemical research into uniquely globally sourced and very rare novel natural extracts both in the USA and overseas to determine the bioavailability, medicinal properties, phytochemistry and therapeutic mechanisms of natural ingredients as they relate to human health. Current research focuses on the evaluation of health-promoting phytochemicals, including major hydrophilic and lipophilic compounds and their respective antioxidant capacities. We use the latest scientific equipment, including LC/MS and NMR technology. The Company utilizes these new drug discoveries for further ongoing design, synthesis, preclinical testing, and manufacturing scale-up to GLP standards from a selection of its appropriate novel lead compounds for their corporate clients, especially in the food and nutraceutical channel. Working iteratively and in close co-operation with our partners, our rational approach to molecular modeling to optimize drug candidates based on our core scaffolds can lead to spectacular new treatment modalities for natural medicines, based on cost-effective strategies. There is a large market gap for new novel ingredients, backed by credible science, either as a stand-alone or “infused”, in other words, to be added to the existing current nutraceutical, pharmaceutical, and food brands to increase and promote wellness and human health. We can give companies a powerful competitive edge. Through reformulation, new improved formulas become a reality. The company has an extensive library of phytochemical footprints and cutting-edge research. All our formulations and backed by science and research, some carried out in the USA.
- Website
-
http://www.genbioinc.com
External link for GenBio Inc.
- Industry
- Biotechnology Research
- Company size
- 2-10 employees
- Headquarters
- Aliso Viejo, CALIFORNIA
- Type
- Privately Held
- Founded
- 2018
- Specialties
- cellular extraction, phytochemical, research, therapeutic, Health, Wellness, lipophilic compounds, hydrophilic compounds, new drug discoveries, natural medicines, treatment modalities, preclinical testing, nutraceuticals, very rare novel natural extracts, formulations, Hybrids, and cutting-edge research
Locations
-
Primary
Get directions
23411 Summerfield
Aliso Viejo, CALIFORNIA 92656, US
Employees at GenBio Inc.
Updates
-
First Human H5N1 Death in the United States — Is This Just the Beginning? This could make Corona look like a day at the beach! The recent detection of a new strain of H5N1 bird flu in US dairy herds has raised alarms among scientists. A US Department of Agriculture report noted that the D1.1 genotype has a mutation that may facilitate the virus spread in mammals, including humans. Concerns are growing amid disruptions in epidemiological data sharing under the Trump administration. “We’re closer than ever to a pandemic with this virus,” Bright warned. “And we’re not yet doing everything we can to prevent it or reduce the impact if it does happen.” Rick Bright, PhD, an American immunologist and former chief executive officer of the Pandemic Prevention Institute at The Rockefeller Foundation.
-
-
CDC webpages go dark as Trump targets public health information | Trump administration | The Guardian https://lnkd.in/d5-Yr_As
-
GenBio Inc. reposted this
GenBio Inc. Partners with PharmaVentures to Accelerate Growth in the Biotechnology Industry https://lnkd.in/gwq9js7u
-
GenBio Inc. reposted this
GenBio Partners with Patent Attorney Michael P. Burns, Esq. to spearhead its #IP program https://lnkd.in/gqtbJy9F
-
The incredible human immune system!
How immune cell chases bacteria and eliminates them. Here's a simplified overview: Detection: Immune cells, such as macrophages and neutrophils, detect the presence of bacteria through various mechanisms, including the recognition of specific molecular patterns on the bacterial surface. Chemotaxis: Once the presence of bacteria is detected, immune cells move toward the site of infection through a process called chemotaxis. Chemical signals released by the bacteria attract immune cells to the location. Adhesion: Immune cells adhere to the surface of the bacteria, facilitated by interactions between receptors on the immune cell and molecules on the bacterial surface. Phagocytosis: The immune cell engulfs the bacterium through a process called phagocytosis. The bacterium is enclosed within a membrane-bound vesicle called a phagosome. Formation of Phagolysosome: The phagosome fuses with lysosomes, which contain enzymes and other substances that can destroy the engulfed bacterium. This fusion forms a phagolysosome. Destruction and Digestion: Enzymes within the phagolysosome break down the bacterial components, neutralizing and digesting them. Reactive oxygen species may also contribute to bacterial destruction. Antigen Presentation: Fragments of the bacterial components, known as antigens, are presented on the surface of the immune cell. This presentation helps activate other immune cells, such as T lymphocytes. Activation of Adaptive Immune Response: Antigen-presenting cells activate specific T cells, initiating an adaptive immune response that enhances the overall immune defense against the specific bacterial threat. Follow me Diella Uka for more. #health #medicine #biology